SevenBridge Financial Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-938
Closed -$274K 215
2025
Q2
$274K Sell
938
-143
-13% -$57.5K 0.05% 180
2025
Q1
$450K Sell
1,081
-214
-17% -$85.9K 0.09% 155
2024
Q4
$507K Sell
1,295
-394
-23% -$165K 0.1% 139
2024
Q3
$719K Buy
1,689
+903
+115% +$482K 0.14% 126
2024
Q2
$412K Hold
786
0.09% 150
2024
Q1
$414K Sell
786
-43
-5% -$21.4K 0.09% 139
2023
Q4
$391K Hold
829
0.09% 140
2023
Q3
$361K Sell
829
-32
-4% -$14.5K 0.09% 139
2023
Q2
$383K Buy
861
+50
+6% +$23.1K 0.1% 135
2023
Q1
$373K Buy
811
+67
+9% +$31.9K 0.1% 140
2022
Q4
$382K Buy
744
+109
+17% +$55.3K 0.11% 137
2022
Q3
$288K Buy
635
+62
+11% +$29.7K 0.1% 139
2022
Q2
$277K Buy
573
+125
+28% +$61.8K 0.11% 117
2022
Q1
$220K Sell
448
-229
-34% -$105K 0.08% 147
2021
Q4
$314K Sell
677
-35
-5% -$14.7K 0.09% 141
2021
Q3
$265K Hold
712
0.09% 144
2021
Q2
$272K Hold
712
0.09% 143
2021
Q1
$256K Hold
712
0.09% 137
2020
Q4
$229K Buy
+712
New +$219K 0.09% 140

Other funds holding ELV

SevenBridge Financial Group's ELV Position: Q3 2025 in Review

SevenBridge Financial Group sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 938 shares — an estimated $274K sold.

SevenBridge Financial Group first reported a position in ELV in Q4 2020 and held it in 19 quarters. The position peaked at $719K in Q3 2024. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • SevenBridge Financial Group reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • SevenBridge Financial Group sold 938 Elevance Health shares in Q3 2025, an estimated $274K.
  • SevenBridge Financial Group first reported a position in Elevance Health in Q4 2020 and held it in 19 quarters.
  • SevenBridge Financial Group's Elevance Health position peaked at $719K in Q3 2024.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on SevenBridge Financial Group's 13F filing for Q3 2025, filed 13 Nov 2025.